N. Burul-Bozkurt Et Al. , "Experimentally-induced diabetes attenuates CCAAT-enhancer binding protein levels in peripheral and central nervous systems," FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.22, pp.91, 2008
Burul-Bozkurt, N. Et Al. 2008. Experimentally-induced diabetes attenuates CCAAT-enhancer binding protein levels in peripheral and central nervous systems. FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.22 , 91.
Burul-Bozkurt, N., Cincioglu, M., Kelicen, P., & Pekiner, C., (2008). Experimentally-induced diabetes attenuates CCAAT-enhancer binding protein levels in peripheral and central nervous systems. FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.22, 91.
Burul-Bozkurt, N. Et Al. "Experimentally-induced diabetes attenuates CCAAT-enhancer binding protein levels in peripheral and central nervous systems," FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.22, 91, 2008
Burul-Bozkurt, N. Et Al. "Experimentally-induced diabetes attenuates CCAAT-enhancer binding protein levels in peripheral and central nervous systems." FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.22, pp.91, 2008
Burul-Bozkurt, N. Et Al. (2008) . "Experimentally-induced diabetes attenuates CCAAT-enhancer binding protein levels in peripheral and central nervous systems." FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.22, p.91.
@article{article, author={N. Burul-Bozkurt Et Al. }, title={Experimentally-induced diabetes attenuates CCAAT-enhancer binding protein levels in peripheral and central nervous systems}, journal={FUNDAMENTAL & CLINICAL PHARMACOLOGY}, year=2008, pages={91} }